See more : American Metals Recovery and Recycling Inc. (AMRR) Income Statement Analysis – Financial Results
Complete financial analysis of Orchid Ventures, Inc. (ORVRF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Orchid Ventures, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Boston International Holdings Plc (BIH.L) Income Statement Analysis – Financial Results
- HAESUNG DS Co., Ltd. (195870.KS) Income Statement Analysis – Financial Results
- Cross Plus Inc. (3320.T) Income Statement Analysis – Financial Results
- Nippon Antenna Co.,Ltd. (NPNZF) Income Statement Analysis – Financial Results
- Ryomo Systems Co.,Ltd. (9691.T) Income Statement Analysis – Financial Results
Orchid Ventures, Inc. (ORVRF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.orchidessentials.com
About Orchid Ventures, Inc.
Orchid Ventures, Inc. engages in the design, development, manufacturing, branding, and distribution of cannabis vape products in North America. The company provides cannabis vapor devices, such as kits and cartridges. It offers its products through approximately 150 dispensaries across California and Oregon. The company also licenses its brand and proprietary hardware to licensed manufacturers and distributors. It serves Cannabis and CBD industries. The company sells its products under the Orchid Essentials brand. Orchid Ventures, Inc. is headquartered in Ladera Ranch, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 3.72M | 1.43M | 5.51M | 2.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 2.52M | 4.91M | 3.54M | 1.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 1.20M | -3.48M | 1.97M | 1.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 32.22% | -244.08% | 35.78% | 50.83% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 3.63M | 1.05M | 8.57M | 1.16M | 79.70K | 74.55K | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 177.86K | 109.04K | 423.79K | 450.38K | -159.00 | 165.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 0.00 | 3.80M | 1.61M | 8.99M | 138.34K | 79.54K | 74.72K | 92.15K | 151.60K | 151.72K | 94.28K |
Other Expenses | 0.00 | 0.00 | 36.24K | 0.00 | 460.44K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 0.00 | 0.00 | 3.95M | 1.61M | 9.00M | 138.34K | 79.54K | 74.72K | 92.15K | 157.08K | 155.67K | 126.73K |
Cost & Expenses | 0.00 | 0.00 | 6.47M | 6.52M | 12.54M | 138.34K | 79.54K | 74.72K | 92.15K | 157.08K | 155.67K | 126.73K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 35.50 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 168.47K | 135.66K | 56.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 167.90K | 228.49K | 153.61K | 243.08K | 13.60K | 10.75K | 862.36K | 22.82K | 0.15 | 0.00 | 0.00 | 0.00 |
EBITDA | 0.00 | 0.00 | -2.92M | -4.85M | -6.62M | 0.00 | 0.00 | -74.55K | -92.11K | -152.08K | -147.56K | -126.73K |
EBITDA Ratio | 0.00% | 0.00% | -69.03% | -340.13% | -118.88% | -5.59% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | 0.00 | 0.00 | -2.72M | -5.10M | -6.57M | -138.34K | -79.54K | -74.72K | -92.14K | -152.08K | -147.56K | -126.73K |
Operating Income Ratio | 0.00% | 0.00% | -73.01% | -357.17% | -119.13% | -5.59% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 0.00 | 0.00 | -381.95K | -1.32M | -123.20K | 10.75K | -145.63K | -2.00 | 34.00 | -15.90K | 23.97K | 0.00 |
Income Before Tax | 0.00 | 0.00 | -3.13M | -6.42M | -6.69M | -137.14K | -225.17K | -74.72K | -92.11K | -167.98K | -123.59K | 0.00 |
Income Before Tax Ratio | 0.00% | 0.00% | -84.25% | -449.63% | -121.36% | -5.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 0.00 | 221.12K | 4.00 | 516.65K | 0.05 | 1.00 | -0.40 | -0.15 | 0.00 | 0.00 | 126.73K |
Net Income | 0.00 | 0.00 | -3.15M | -6.42M | -6.69M | -137.14K | -225.17K | -74.72K | -92.11K | -167.98K | -123.59K | -126.73K |
Net Income Ratio | 0.00% | 0.00% | -84.69% | -449.63% | -121.36% | -5.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | 0.00 | 0.00 | -0.06 | -0.49 | -3.39 | -0.03 | -0.38 | -0.13 | -0.16 | -0.10 | -0.08 | -0.36 |
EPS Diluted | 0.00 | 0.00 | -0.06 | -0.49 | -3.39 | -0.03 | -0.38 | -0.13 | -0.16 | -0.10 | -0.08 | -0.36 |
Weighted Avg Shares Out | 0.00 | 0.00 | 52.44M | 13.11M | 1.97M | 4.00M | 594.58K | 594.58K | 588.76K | 1.70M | 1.50M | 353.33K |
Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 52.44M | 13.11M | 1.97M | 4.00M | 594.58K | 594.58K | 588.76K | 1.70M | 1.50M | 353.33K |
Orchid Ventures Announces Shareholder Update Conference Call
Eybna Announces Q3 Partnerships with Legacy Brands, Fueling National Expansion
Orchid Ventures Announces Highest Month of Sales Closed in Nine Months
Orchid Ventures Announces the PurGuard Vape Software Platform With Age Verification to Limit Vape Usage by Minors
Orchid Ventures Announces Its CEO to Speak at the Summer Emerge Conference
Orchid Ventures Consolidated its Shares and Closes Over-Subscribed Private Placement of Units
Orchid Ventures Amends the Terms of Warrants Issued in 2019
Orchid Ventures Announces Proposed Share Consolidation, Private Placement of Units and Shares for Debt Settlement
Orchid Ventures Reports Annual Financial Results for Fiscal Year 2020
Orchid Ventures Provides Financial Filings Update
Source: https://incomestatements.info
Category: Stock Reports